Reuters exclusively reported that a U.S. lawmaker involved in health policy has asked the Food and Drug Administration why it did not inspect Elon Musk’s Neuralink before allowing the brain implant company to test its device in humans.
Related stories
Exclusives | Americas
Read more
Peru plans bond sales to finance ballooning fiscal deficit, minister says
29 January 2025
News First | Americas
Read more
Boeing warns of bigger-than-expected $4 billion quarterly loss; shares drop
24 January 2025
Exclusives | Americas
Read more